Yojiro Sudo

Modulation of multidrug resistance by taxuspine C and other taxoids from Japanese yew

Jun’ichi Kobayashi, Hirokazu Hosoyama, Xiaoxia Wang et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 36 citations

Medicine, Pharmacology, Pharmacotherapy +8

A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.

T Tsuruo, Keisuke Yusa, Yojiro Sudo et al. · PubMed · 1989 · 20 citations

Medicine, Oncology, Pharmacology +7

Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(?-l-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo

Takashi Tsuruo, Yojiro Sudo, N Asami et al. · Cancer Chemotherapy and Pharmacology · 1990 · 16 citations

Medicine, Oncology, Pharmacology +11

A benzophenazine derivative,N-β-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxy-benzo[a]phenazine-6-carboxamide, as a new antitumor agent against multidrug-resistant and sensitive tumors

Takashi Tsuruo, Mikihiko Naito, R Takamori et al. · Cancer Chemotherapy and Pharmacology · 1990 · 12 citations

Medicine, Oncology, Pharmacology +8

Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.

T Tsuruo, Tomoko Oh‐hara, Yojiro Sudo et al. · PubMed · 1993 · 12 citations

Medicine, Oncology, Pharmacology +13